ArticleACS infectious diseases2019
Design and Application of a High-Throughput, High-Content Screening System for Natural Product Inhibitors of the Human Parasite
Open access · greenAbstract read
In one paragraph
Article in ACS infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.4field-weighted citation impact, top 21% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed, 19 citations in OpenAlex.
- Systematic Assessment of the Impact of Targeted Selection Methods and Environment-Mimicking Culture Conditions on Fungal Natural Product Libraries.Journal of natural products · 2026Article
- Article
- Semisynthetic Tetramate-Containing Fungal Metabolites with Activity againstACS medicinal chemistry letters · 2024Article
- Rationally Minimizing Natural Product Libraries Using Mass Spectrometry.bioRxiv : the preprint server for biology · 2024Article
- Appraisal of Fungus-Derived Xanthoquinodins as Broad-Spectrum Anti-Infectives Targeting Phylogenetically Diverse Human Pathogens.Journal of natural products · 2023Article
- Identification of Leucinostatins fromACS omega · 2022Article
- Building Natural Product Libraries Using Quantitative Clade-Based and Chemical Clustering Strategies.mSystems · 2021Article
- Deazapurine Nucleoside Analogues for the Treatment ofACS infectious diseases · 2021Article
- Anti-trichomonad activities of different compounds from foods, marine products, and medicinal plants: a review.BMC complementary medicine and therapies · 2020Review
- Isolation of Unstable Isomers of Lucilactaene and Evaluation of Anti-Inflammatory Activity of Secondary Metabolites Produced by the Endophytic FungusMolecules (Basel, Switzerland) · 2020Article
- Hyalodendrins A and B, New Decalin-Type Tetramic Acid Larvicides from the Endophytic Fungus Hyalodendriella sp. Ponipodef12.Molecules (Basel, Switzerland) · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 1 institution in 1 country.
Jarrod B KingNatural Products Discovery Group, Institute for Natural Products Applications and Research Technologies, Department of Chemistry and Biochemistry, Stephenson Life Sciences Research Center , University of Oklahoma , 101 Stephenson Parkway , Room 1000, Norman , Oklahoma 73019 , United States.
Adam C CarterNatural Products Discovery Group, Institute for Natural Products Applications and Research Technologies, Department of Chemistry and Biochemistry, Stephenson Life Sciences Research Center , University of Oklahoma , 101 Stephenson Parkway , Room 1000, Norman , Oklahoma 73019 , United States.
Wentao DaiNatural Products Discovery Group, Institute for Natural Products Applications and Research Technologies, Department of Chemistry and Biochemistry, Stephenson Life Sciences Research Center , University of Oklahoma , 101 Stephenson Parkway , Room 1000, Norman , Oklahoma 73019 , United States.
Jin Woo LeeNatural Products Discovery Group, Institute for Natural Products Applications and Research Technologies, Department of Chemistry and Biochemistry, Stephenson Life Sciences Research Center , University of Oklahoma , 101 Stephenson Parkway , Room 1000, Norman , Oklahoma 73019 , United States.
Yun-Seo KilNatural Products Discovery Group, Institute for Natural Products Applications and Research Technologies, Department of Chemistry and Biochemistry, Stephenson Life Sciences Research Center , University of Oklahoma , 101 Stephenson Parkway , Room 1000, Norman , Oklahoma 73019 , United States.
Lin DuNatural Products Discovery Group, Institute for Natural Products Applications and Research Technologies, Department of Chemistry and Biochemistry, Stephenson Life Sciences Research Center , University of Oklahoma , 101 Stephenson Parkway , Room 1000, Norman , Oklahoma 73019 , United States.ORCID 0000-0001-8751-4482
Sara K HelffNatural Products Discovery Group, Institute for Natural Products Applications and Research Technologies, Department of Chemistry and Biochemistry, Stephenson Life Sciences Research Center , University of Oklahoma , 101 Stephenson Parkway , Room 1000, Norman , Oklahoma 73019 , United States.
Shengxin CaiNatural Products Discovery Group, Institute for Natural Products Applications and Research Technologies, Department of Chemistry and Biochemistry, Stephenson Life Sciences Research Center , University of Oklahoma , 101 Stephenson Parkway , Room 1000, Norman , Oklahoma 73019 , United States.
Brandt C HuddleNatural Products Discovery Group, Institute for Natural Products Applications and Research Technologies, Department of Chemistry and Biochemistry, Stephenson Life Sciences Research Center , University of Oklahoma , 101 Stephenson Parkway , Room 1000, Norman , Oklahoma 73019 , United States.
Robert H CichewiczNatural Products Discovery Group, Institute for Natural Products Applications and Research Technologies, Department of Chemistry and Biochemistry, Stephenson Life Sciences Research Center , University of Oklahoma , 101 Stephenson Parkway , Room 1000, Norman , Oklahoma 73019 , United States.ORCID 0000-0003-0744-4117
University of Oklahoma · US
Funding
Early Stage Discovery of Natural Products Targeting Anaerobic Protozoal PathogenR33AI119713 · NIAID · UNIVERSITY OF OKLAHOMA · PI CICHEWICZ, ROBERT HENRY · 2017 to 2019
$1.4MNIAID NIH HHS R33 AI119713
Abstract
It is estimated that
Indexed as
Antiprotozoal AgentsBiological ProductsCell LineDrug DiscoveryFemaleFibroblastsFungiHigh-Throughput Screening AssaysHumansImage Processing, Computer-AssistedPyrrolidinonesQuinonesSensitivity and SpecificityTrichomonas vaginalisTrichomonas VaginitisAntiprotozoal AgentsBiological ProductsPyrrolidinonesQuinonestetramic acidfunginatural productsquinonestetramic acid
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.